Insider trading

Period: 120 months Stock: AURA Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

56 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

56 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

56 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

56 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
56 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
56 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

56 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Jun 2026
Gibney Anthony S See Remarks
Sold at will
$82.33K 12,824 at 6.42
4.6%
Not planned
7 May 2026
Sold at will
$39.04M 6,922,870 at 5.64
100%
Sold half or more
16 Apr 2026
Kilroy Conor See Remarks
Sold at will
$82.40K 11,738 at 7.02
5.1%
Not planned
17 Feb 2026
de los Pinos Elisabet See Remarks
Sold at will
$241.10K 47,648 at 5.06
10.4%
Not planned
17 Feb 2026
Hopkins Janet Jill Chief Medical Officer
Sold at will
$103.23K 20,401 at 5.06
8.1%
Not planned
17 Feb 2026
Plavsic Mark Chief Technology Officer
Sold at will
$80.24K 15,890 at 5.05
8.1%
Not planned
17 Feb 2026
Kilroy Conor See Remarks
Sold at will
$61.00K 12,079 at 5.05
6.7%
Not planned
17 Feb 2026
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$43.26K 8,549 at 5.06
10.2%
Not planned
20 Jan 2026
de los Pinos Elisabet See Remarks
Sold at will
$82.27K 16,928 at 4.86
3.6%
Not planned
20 Jan 2026
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$7.68K 1,581 at 4.86
1.8%
Not planned
17 Nov 2025
Hopkins Janet Jill Chief Medical Officer
Sold at will
$92.73K 17,109 at 5.42
6.3%
Not planned
29 Oct 2025
de los Pinos Elisabet See Remarks
Sold at will
$57.46K 9,049 at 6.35
1.9%
Not planned
29 Oct 2025
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$5.69K 896 at 6.35
1.0%
Not planned
16 Oct 2025
Plavsic Mark Chief Technology Officer
Sold at will
$77.27K 12,169 at 6.35
5.8%
Not planned
18 Aug 2025
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$51.74K 7,722 at 6.70
8.2%
Not planned
16 May 2025
Gibney Anthony S See Remarks
Bought
$245.00K 50,000 at 4.90
592%
First buy on file
16 May 2025
Bought
$98.00K 20,000 at 4.90
13.7%
16 May 2025
Gibney Anthony S See Remarks
Sold at will
$7.82K 1,519 at 5.15
2.6%
Not planned
16 Apr 2025
Kilroy Conor See Remarks
Sold at will
$39.32K 7,162 at 5.49
3.8%
Not planned
16 Apr 2025
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$4.92K 897 at 5.49
1.1%
Not planned
18 Feb 2025
de los Pinos Elisabet See Remarks
Sold at will
$156.80K 20,221 at 7.75
4.0%
Not planned
18 Feb 2025
Hopkins Janet Jill Chief Medical Officer
Sold at will
$19.64K 2,534 at 7.75
0.9%
Not planned
18 Feb 2025
Plavsic Mark Chief Technology Officer
Sold at will
$16.67K 2,151 at 7.75
1.0%
Not planned
18 Feb 2025
Elazzouzi Amy Senior Vice President, Finance
Sold at will
$10.88K 1,404 at 7.75
1.7%
Not planned
21 Jan 2025
de los Pinos Elisabet See Remarks
Sold at will
$122.38K 15,955 at 7.67
5.0%
Not planned
21 Jan 2025
Elazzouzi Amy Vice President, Finance
Sold at will
$7.68K 1,001 at 7.67
2.5%
Not planned
18 Nov 2024
Hopkins Janet Jill Chief Medical Officer
Sold at will
$110.66K 11,822 at 9.36
7.2%
Not planned
29 Oct 2024
de los Pinos Elisabet See Remarks
Sold at will
$98.79K 9,200 at 10.74
2.8%
Not planned
29 Oct 2024
Elazzouzi Amy Vice President, Finance
Sold at will
$5.94K 553 at 10.74
1.4%
Not planned
16 Oct 2024
Plavsic Mark Chief Technology Officer
Sold at will
$72.72K 7,383 at 9.85
5.7%
Not planned
23 Jan 2024
de los Pinos Elisabet See Remarks
Sold at will
$121.14K 15,853 at 7.64
8.9%
Not planned
23 Jan 2024
Feder Julie B Chief Financial Officer
Sold at will
$50.52K 6,609 at 7.64
9.5%
Not planned
9 Nov 2023
Bought
$14.04M 1,560,000 at 9.00
29.1%
+29% of stake
8 Nov 2023
Johnson David Michael Director · indirect
Bought 2×
$146.00K 20,000 at 7.30
36.4%
+36% of stake
8 Nov 2023
Bought
$70.09K 9,601 at 7.30
7.6%
7 Nov 2023
Johnson David Michael Director · indirect
Bought 2×
$673.98K 94,000 at 7.17
opened
Largest buy in 3 yrs
7 Nov 2023
Bought
$544.92K 76,000 at 7.17
152%
Largest buy in 3 yrs
30 Oct 2023
de los Pinos Elisabet See Remarks
Sold at will
$65.48K 9,586 at 6.83
5.0%
Not planned
30 Oct 2023
Feder Julie B Chief Financial Officer
Sold at will
$23.09K 3,385 at 6.82
4.6%
Not planned
4 Oct 2023
Bought
$56.51K 6,566 at 8.61
15.1%
3 Oct 2023
Bought
$111.66K 13,500 at 8.27
45.0%
+45% of stake
6 Jan 2023
Johnson David Michael Director · indirect
Bought 2×
$16.85K 1,604 at 10.51
9.8%
5 Jan 2023
Johnson David Michael Director · indirect
Bought 2×
$3.96K 396 at 10.00
2.3%
28 Dec 2022
Johnson David Michael Director · indirect
Bought 2×
$39.00K 4,000 at 9.75
30.8%
+31% of stake
5 Dec 2022
Bought
$15.00M 1,250,000 at 12.00
30.4%
+30% of stake
1 Dec 2022
Johnson David Michael Director · indirect
Bought 2×
$123.70K 10,000 at 12.37
200%
+200% of stake
31 Oct 2022
de los Pinos Elisabet See Remarks
Sold, plan not stated
$71.08K 5,706 at 12.46
7.7%
31 Oct 2022
Feder Julie B Chief Financial Officer
Sold, plan not stated
$25.09K 2,015 at 12.45
7.7%
31 Oct 2022
Rich Cadmus See Remarks
Sold, plan not stated
$20.81K 1,672 at 12.45
6.4%
31 Oct 2022
De Rosch Mark Chief Operating Officer
Sold, plan not stated
$13.89K 1,115 at 12.46
6.4%
Showing 1–50 of 56. Page 1 of 2 Older →